Partner
Mark Adams is a partner at Two Bear Capital, where he focuses on life sciences, artificial intelligence and cybersecurity companies. Mark was most recently COO and CTO at Adaptive Biotechnologies, a public biotechnology company in Seattle. He has previously had C-suite roles in several biotechnology companies, as well as leading a consulting practice at Booz Allen Hamilton. He has also led artificial intelligence and data science teams in finance at Bridgewater Associates and Leerink Partners. Mark holds a Ph.D. in molecular biology from Baylor College of Medicine and he earned his B.A. in Biology and Computer Science from Oberlin College.